Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Lymphoid 3Thoracic 1Other solid neoplasm 1

Conditions

Lymphoma, B-Cell, Marginal Zone 2Lymphoma, Non-Hodgkin 1Lymphoma 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 282Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Tetracycline × Lymphoid × Clear all
NCT07144657 2025-08-27

GastricMALToma

National Taiwan University Hospital

Phase 2 Not yet recruiting
40 enrolled
Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT00002682 2018-10-24

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

M.D. Anderson Cancer Center

Phase 2 Completed
5 enrolled
Lymphoid

Lymphoma, Lymphoma, B-Cell, Marginal Zone

NCT01010295 2013-11-25

IELSG27

International Extranodal Lymphoma Study Group (IELSG)

Phase 2 Completed
54 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡